Displaying results 1 - 12 of 152
Immune-Mediated and Cholestatic Diseases

Welcome & General Introduction (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Keynote Lecture (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Session 1: Validation of Surrogate Endpoints (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Session 3: Symptom Assessment in Trials (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Panel Discussion and Meeting Conclusion (Complete Session)

Webcasts
View
Liver Tumours

Session 2: Leveraging Real-World Evidence (Complete Session)

Webcasts
View
Liver Tumours

Session 1: Overview of End-Points and Trial Design (Complete Session)

Webcasts
View
Liver Tumours

Session 2: Design and End-Points in Trials for Early and Intermediate HCC (Complete Session)

Webcasts
View
Liver Tumours

Session 3: Design and End-Points in Trials for Advanced HCC (Complete Session)

Webcasts
View
Liver Tumours

Session 4: Emerging Topics in Trial Design and regulatory strategies (Complete Session)

Webcasts
View
General Hepatology

Final results of MYR301: a randomised phase 3 study evaluating the efficacy and safety of up to 144 weeks of bulevirtide monot...

Webcasts
View
General Hepatology

High prevalence of undiagnosed liver fibrosis in the adult european population driven by metabolic risk factors and alcohol co...

Webcasts
View
Displaying results 1 - 12 of 152